Leveraging the IDN Dataset: Your Essential Tool for 2025

Article

Leveraging the IDN Dataset: Your Essential Tool for 2025

January 28, 2025
Authors
Topics

As IDNs face increasing complexity in oncology management, having a strategic approach backed by actionable insights is critical. Our dataset doesn’t just offer data—it equips your teams with the tools to anticipate challenges and seize opportunities.

Leveraging the IDN Dataset: Your Essential Tool for 2025

As 2025 gets underway, reconnecting with key accounts is top of mind for many. For oncology drug manufacturers, having the right tools to navigate these conversations is critical. That’s where our Integrated Delivery Network (IDN) Dataset comes in, providing the insights and clarity you need to drive meaningful engagement with 147 unique IDNs.

What Makes the IDN Dataset Stand Out?

The dataset includes comprehensive demographic and process data tailored to help you better understand and connect with IDNs, including:

  • 52 NCI cancer centers
  • 29 NCCN members
  • 96 academic health systems

This online dashboard enables you to anticipate and address the needs of IDN stakeholders effectively.

Leveraging the IDN Dataset: Your Essential Tool for 2025

Key Features at Your Fingertips

Our IDN-at-a-Glance Dashboard, accessible via our online portal, simplifies preparation for account teams by offering:

  • Quick Demographics Access: From the number of hospitals and oncologists to 340B eligibility and oral dispensing capabilities, key data are easily available.
  • Drug Assessment Insights: Understand P&T committees, evaluation criteria, and oncology subcommittees to streamline your engagement strategy.
  • Tailored Support for Stakeholder Needs: Provide the right data, such as trial data and total cost of care information, to match IDN-specific priorities.
  • Drug Management Overview: Quickly identify controls like order sets and pathways that influence treatment prescribing.

Now Available in Snowflake

We’ve enhanced accessibility by making our dataset available in Snowflake.

Looking Ahead

As IDNs face increasing complexity in oncology management, having a strategic approach backed by actionable insights is critical. Our dataset doesn’t just offer data—it equips your teams with the tools to anticipate challenges and seize opportunities.  

Have questions? Reach out to our team or learn more about the portal with our IDN dataset overview! Send me a note at ebijesse@hmpglobal.com.  


Additional Resources

The Latest

Meet Ashutosh Sheth
Article
Meet Ashu: Organizer & Researcher Extraordinaire; Artist at Heart

Ashu is the glue that keeps our team organized and running smoothly. This year, he’s been particularly fascinated by the growing consolidation among community practices and how it’s reshaping the oncology landscape.

Ashutosh Sheth
Beyond AMCs: CAR Ts and Bispecifics in Community Oncology
Article
Beyond AMCs: CAR Ts and Bispecifics in Community Oncology

CAR T-cell and BsAb therapies are powerful but largely confined to AMCs, limiting patient access. Our latest report explores how expanding to community oncology could improve access, addressing key clinical, logistical, and financial challenges.

Chris Van Denburg
Not only does Emma have over a decade of experience supporting academic health systems and integrated delivery networks (IDNs), but she’s also the go-to for a delicious apple pie.
Article
Meet Emma: Research Leader and Master Baker

Not only does Emma have over a decade of experience supporting academic health systems and integrated delivery networks (IDNs), but she’s also the go-to for a delicious apple pie.

Emma Bijesse